Literature DB >> 16437001

Adam Politzer (1835-1920) and the description of otosclerosis.

Albert Mudry1.   

Abstract

In 1893, Adam Politzer was the first to describe otosclerosis as a specific disease fixating the stapes. The aim of this study is to follow Politzer's research to understand how he finally explained the mechanism responsible for the fixation of the stapes. Politzer conducted his preliminary research from 1862 to 1893. From the concept of a dry catarrh of the middle ear, the fixation of the stapes became progressively associated with a specific ossification in and around the footplate. Politzer presented his first results in 1893. He completed his research by concluding in 1901 that otosclerosis had become an independent disease and should have the right to its own chapter in otologic books. He selected the word otosclerosis to describe this new pathologic entity.

Entities:  

Mesh:

Year:  2006        PMID: 16437001     DOI: 10.1097/01.mao.0000187050.04286.80

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  4 in total

1.  Is one of these two techniques: CO2 laser versus microdrill assisted stapedotomy results in better post-operative hearing outcome?

Authors:  Nasser M Altamami; Gunther Huyghues des Etages; Maxime Fieux; Aurélie Coudert; Ruben Hermann; Sandra Zaouche; Eric Truy; Stéphane Tringali
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-04       Impact factor: 2.503

2.  Delaying partial stapedectomy for otosclerosis: effects on long-term hearing outcomes following surgery.

Authors:  Anastasios Maniakas; Jade Nehme; Jean-Jacques Dufour; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

Review 3.  Contemporary techniques in human otopathology and promise for the future.

Authors:  Joseph B Nadol
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-12-23

Review 4.  History of otorhinolaryngology in Germany before 1921.

Authors:  Albert Mudry; Robert Mlynski; Burkhard Kramp
Journal:  HNO       Date:  2021-04-13       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.